Mosaicism in bcr-abl protein expression in B cells in chronic myelogenous leukemia

International Journal of Cancer

Volumn 68, Issue 5, 1996, Pages 577-582

  Weissinger, Eva M ^a,d   Thalmeier, Karin ^a,b   Düll, Thomas ^a,b,c   Grammer, Christine ^a,b,c   Kempkes, Bettina ^a,b,c   Brielmeier, Markus ^a,b,c   Schumm, Michael ^a,b,c,d   Kolb, Hans Jochem ^a,b,c  

^a Institutes for Clinical Hematology   (Germany)

^b Experimental Hematology ^*

^c Clinical Molecular Biology and Tumor Genetics   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; HYDROXYUREA; MESSENGER RNA;

ARTICLE; B LYMPHOCYTE; CELL LINE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOSAICISM; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; GENETICS; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION;

B-LYMPHOCYTES; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029658441     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961127)68:5<577::AID-IJC4>3.0.CO;2-W     Document Type: Article

References (23)

1. ADVANI, S.H., MALHOTRA, H., KADAM, P.R., IYER, R.S., NAJANGUD, G., BALSARA, B., SAIKIA, T., GOPAL, R. and NAIR, C.N., T-lymphoid blast crisis in chronic myeloid leukemia. Amer. J. Hematol.,36, 86-92 (1991).
2. BAKHSHI, A., MINOWADA, J., ARNOLD, A., COSSMAN, J., JENSEN, J.P., WHANG-PENO, J., WALDMANN, T.A. and KORSMEYER, S.J., Lymphoid blast crises of chronic myelogenous leukemia represent stages in development of B-cell precursors. New Engl. J. Med.,309, 826-831 (1983).
3. CH'ANG, H.J., TIEN, H.F., CHUANG, S.M., CHEN, Y.C., SHEN, M.C., LIN, D.T. and LIN, K.H., Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia-chromosome-positive chronic myeloid leukemia. Cancer Genet. Cylogenet.,71, 87-93 (1993).
4. DERDERIAN, P.M., KANTARJIAN, H.M., TALPAZ, M., O'BRIEN, S., CORK, A., ESTEY, E., PIERCE, S. and KEATING, M., Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response and prognosis. Amer. J. Med.,94, 69-74 (1993).
5. DUBÈ, I.D., EAVES, C.J., KALOUSEK, D.K. and EAVES, A.C., A method for obtaining high-quality chromosome preparations from single hematopoietic colonies on a routine basis. Cancer Genet. Cytogenet.,4, 157-163 (1981).
6. GRAY, D., Population kinetics of rat peripheral B cells. J. exp. Med.,167, 805-807 (1988).
7. GRIFFIN, J.D., TODD, R.F. III, RITZ, J., NADLER, L.M., CANELLOS, O.P., ROSENTHAL, D., GALLIVAN, M., BEVERIDGE, R.P., WEINSTEIN, H., KARP, D. and SCHLOSSMANN, S.F., Differentiation patterns in blastic phase of chronic myeloid leukemia. Blood, 61, 85-91 (1983).
8. GUO, J.Q., LIAN, J.Y., XIAN, Y.M., LEE, M.S., DEISSEROTH, A.B., STASS, S.A., CHAMPLIN, R.E., TALPAZ, M., WANG, J.Y.J. and ARLINGHAUS, R.B., BCR-ABL protein expression in peripheral-blood cells of chronic-myelogenous-leukemia patients undergoing therapy. Blood, 83, 3629-3634 (1994).
9. JONAS, D., LÜBBERT, M., KAWASAKI, E.S., HENKE, M., BROSS, K.J., MERTELSMANN, R. and HERRMANN, F., Clonal analyses of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia. Blood, 79, 1017-1023 (1992).
10. KANTARJIAN, H.M., DEISSEROTH, A., KURZROCK, R., ESTROV, Z. and TALPAZ, M., Chronic myelogenous leukemia: a concise update. Blood, 82, 691-703 (1993).
11. KAWASAKI, E.S., CLARK, S.S., COYNE, M.Y., SMITH, S.D., CHAMPLIN, R., WITTE, O.N. and McCoRMiCK, P.P., Diagnosis of chronic myeloid and acute leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. not. Acad. Sei. (Wash.), 85, 5698-5702 (1988).
12. LOZZIO, C.B. and LOZZIO, B.B., Human chronic-myelogenous-leukemia cell line with positive Philadelphia chromosome. Blood, 45, 321-334 (1975).
13. MARTIN, P.J., NAJFELD, V., HANSEN, J.A., PENFOLD, G.K., JACOBSON, R.J. and FIALKOW, P.J., Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature (Lond.), 287, 49-50 (1980).
14. NITTA, M., KATO, Y., STRIFE, A., WACHTER, M., FRIED, J., PEREZ, A., JHANWAR, S., DUIGOU-OSTERNDORF, R., CHAGANTI, R.S.K. and CLARKSON, B., Incidence of involvement of the B- and T-lymphocyte lineages in chronic myelogenous leukemia. Blood, 66, 1053-1061 (1985).
15. RASKIND, W.H., FERRARIS, A.M., NAJFELD, V., JACOBSON, R.J., MOOHR, J.W. and FIALKOW, P.J., Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia. Leukemia, 7, 1163-1167 (1993).
16. ROTH, M.S., ANTIN, J.H., BINGHAM, E.L. and GINSBURG, D., Detection of Philadelphia-chromosome-positive cells by the polymerase chain reaction following bone-marrow transplant for chronic myelogenous leukemia. Blood, 74, 882-888 (1989).
17. ROWLEY, J.D., A new and consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature (Loud.), 243, 290-293 (1973).
18. SCHIFF-MAKER, L., BURNS, M.C., KONOPKA, J.B., CLARK, S., WITTE, O.N. and ROSENBERG, N., Monoclonal antibodies specific for v-abl-and c-abl-encoded molecules. J. Virol.,57, 1182-1186 (1986).
19. SHTIEVELMAN, E., LIFSHITZ, B., GALE, R.P., ROE, B.A. and CANAAI, E., Alternative splicing of RNAs transcribed from human abl gene and from the bcr-abl fused gene. Cell, 47, 227-237 (1986).
20. SILVER, R.T., Chronic myeloid leukemia. A perspective of clinical and biologic issues of the chronic phase. Heniatol. Oncol. Clin. North. Amer.,4, 319-355 (1990).
21. VON KNEBEL DOEBERITZ, M., BORNKAMM, G.W. and ZUR HAUSEN, H., Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A. Med. Microbiol. Imnumol.,172, 87-99 (1983).
22. WEINSTEIN, M.E., GROSSMANN, A., PERLE, M.A., WILMOT, P.L., VERMA, R.S., SILVER, R.T., ARLIN, Z., ALLEN, S.L., AMOROSI, E., WAINTRAUB, S.E., SHARPIO, L.R. and BENN, P.A., The karyotype of Philadelphia-chromosome-negative, breakpoint-cluster-region-rearrangement-positive chronic myeloid leukemia. Cancer Genet. Cytogcnet.,3, 223-229 (1988).
23. WEISSINGER, E.M., HENDERSON, D.W., MISCHAK, H., GOODNIGHT, J. and MUSHINSKI, J.F., Induction of plasmacytomas that secrete monoclonal anti-peptide antibodies by retroviral transformation. J. immunol. Meth.,168, 123-130 (1994).